Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
HDAI is an health care analytics company with a platform that creates a shared understanding of health risks and personalized care profiles.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Rapido provides a platform for booking bike taxis, autos, and cabs.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.
Aive is a technology company that provides an AI-driven video post-production platform as software-as-a-service.
Bambusa Therapeutics operates as biotechnology company.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
BRIUS is a healthcare company that focuses in the orthodontics and medical device industry.
ClearScore is a fintech company that provides free credit scores, credit reports, and financial product recommendations to consumers.
Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Amount is a digital technology company that accelerates digital transformation for financial institutions.
Neptune Medical is a medical device company that develops endoscopic and surgical devices.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Invus has invested in 104 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Life Science. The firm invests across 41 different industry categories.
Among tracked funding rounds, TigerConnect received $300.0M in a Private Equity round. Invus's total known invested capital is $7.4B.
Invus's average investment size is $80.3M across its portfolio of 104 companies.
Recent Invus portfolio additions include MaaT Pharma, TigerConnect, Valo Health, Health Data Analytics Institute, Rani Therapeutics. These companies were founded in 2020 or later.